SEPSECS
protein-codingSep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase
Gene summary
The amino acid selenocysteine is the only amino acid that does not have its own tRNA synthetase. Instead, this amino acid is synthesized on its cognate tRNA in a three step process. The protein encoded by this gene catalyzes the third step in the process, the conversion of O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec).[provided by RefSeq, Mar 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~40.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0016759
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013438
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013438
Submitter: Natera
Inheritance Pattern: AR
Disease ID:MONDO:0016589
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013438
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0013438
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013438
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013438
Submitter: Broad Center for Mendelian Genomics
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SEPSECS variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_016955.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 7 | 179 | 187 | ||
| missense | 1 | 10 | 142 | 3 | 1 | 157 |
| nonsense | 11 | 21 | 1 | 33 | ||
| start loss | 1 | 1 | 2 | |||
| frameshift | 28 | 29 | 57 | |||
| splice donor/acceptor (+/-2bp) | 20 | 2 | 22 | |||
| Total | 42 | 81 | 152 | 182 | 1 | 458 |
Highest pathogenic variant AF is 0.00008181146
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_058651.3 | 11 | MANE Select | |
| Ensembl | ENSP00000371535.2 | 11 | MANE Select | |
| RefSeq | NP_001397643.1 | 12 | Standard | |
| Ensembl | ENSP00000351857.3 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Selenocompound metabolism - Homo sapiens (human)
- Aminoacyl-tRNA biosynthesis - Homo sapiens (human)
- Selenium Metabolism and Selenoproteins
- Selenocysteine synthesis
- Metabolism of amino acids and derivatives
Biological Process
- selenocysteine incorporation
- selenocysteine metabolic process
- selenocysteinyl-tRNA(Sec) biosynthetic process
Molecular Function
- tRNA binding
- protein binding
- phosphoseryl-selenocysteinyl-tRNA selenium transferase activity
Cellular Component
- nucleus
- cytoplasm
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000382103
- Coding exons
- 11
- Length
- 40578
- Individuals with no LoFs
- 125583
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 165
- Defined
- 125748
- p
- 0.000656
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.0214 | 269 | 270 | 0.996 | 0.0000128 | 3260 |
| Missense (PolyPhen) | 94 | 105.42 | 0.89171 | 1293 | ||
| Synonymous | 2.10 | 69 | 95.0 | 0.726 | 0.00000455 | 972 |
| Loss of Function | 1.60 | 16 | 24.6 | 0.651 | 0.00000138 | 295 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00026 | 0.00026 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.0054 | 0.0054 | notable |
| European (Non-Finnish) | 0.00023 | 0.00023 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Converts O-phosphoseryl-tRNA(Sec) to selenocysteinyl- tRNA(Sec) required for selenoprotein biosynthesis. {ECO:0000269|PubMed:17142313}.;
Recessive Scores
- pRec
- 0.156
Intolerance Scores
- LoFtool
- 0.412
- RVIS EVS
- 0
- RVIS percentile EVS
- 53.73
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- N
- Indispensability score
- 0.209
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |